Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aberle DR, Balmes JR. Computed tomography of asbestos-related parenchymal and pleural diseases. Clin Chest Med 1991; 12: 115–131
Alkhuja S, Miller A, Mastellone AJ et al. Malignant pleural mesothelioma presenting as spontaneous pneumothorax: A case series and review. Am J Ind Med 2000; 38: 219–223
Antman KH, Pass HI, Li FP et al. Benign and malignant mesothelioma, cancer. In: Principles and practice of oncology, 4th edn 1993; 1489–1508
Antman KH. Natural history and epidemiology of malignant mesothelioma. Chest 1993; 103(Suppl 4): 373–376
Bénard F, Sterman D, Smith RJ et al. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 1998; 114: 713–722
Boutin C, Nussbaum E, Monnet I et al. Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer 1994; 74: 2460–2467
Butchart EG, Ashcroft T, Barnsley WC et al. Pleuropneumectomy in the management of diffuse malignant mesothelioma of the pleura: Experience with 29 patients. Thorax 1976; 31:15–24
Campbell GD, Greenberg SD. Pleural mesothelioma with calcified liver metastases. Chest 1981; 79: 229–230
Carretta A, Landoni C, Melloni G et al. 18-FDG positron emission tomography in the evaluation of malignant pleural disease — a pilot study. Eur J Card Thorac Surg 2000; 17: 377–383
Connelly RR, Spirtas R, Myers MH et al. Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 1987; 78: 1053–1060
Craighead JE. Current pathogenetic concepts of diffuse malignant mesothelioma. Hum Pathol 1987; 18: 544–557
De Pangher MV, Manzini V, Brollo A et al. Prognostic factors of malignant mesothelioma of the pleura. Cancer 1993; 72: 410–417
Gorich J, Beyner-Enke SA, Flentje M et al. Evaluation of recurrent bronchogenic carcinoma by computed tomography. Clin Imag 1990; 14: 131–137
Heelan RT, Rusch VW, Begg CB et al. Staging of malignant pleural mesothelioma: Comparison of CT and MR imaging. AJR Am J Roentgenol 1999; 172: 1039–1047
Heller RM, Janower ML, Weber AL. The radiologic manifesta-tions of malignant pleural mesothelioma. Am J Roentgenol Radium Ther Nucl Med 1970; 108: 53–59
Herndon JE, Green MR, Chahinian AP et al. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 1998; 113: 723–731
Hillerdal G. Malignant mesothelioma 1982: Review of 4710 published cases. Br J Dis Chest 1983; 77: 321–343
Hillerdal G. Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest 1994; 105: 144–150
Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000; 44: 565–601
Knuuttlila A, Kivisaari L, Kivisaari A et al. Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma. Acta Radiol 2001; 42:502–507
Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol 1990; 154: 487–492
Light RW. Pleural diseases. Lea and Febiger, Philadelphia, 1995; 117–128
Marom EM, Erasmus JJ, Pass HI et al. The role of imaging in malignant pleural mesothelioma. Sem Oncol 2002; 29: 26–35
McLoud TC. CT and MR in pleural disease. Clin Chest Med 1998; 19: 261–276
Metintas M, Ucgun I, Elbek O et al. Computer tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 2002; 41: 1–9
Miller BH, Rosado-de-Christenson ML, Mason AC. et al. From the archives of the AFIP. Malignant pleural mesothelioma: Radiologic-pathologic correlation. Radiographics 1996; 16: 613–644
Mossman BT. Carcinogenesis and related cell and tissue responses to asbestos: a review. Ann Occup Hyg 1994; 38: 617–624
Müller NL. Imaging of the pleura. Radiology 1993; 186: 298–309
Neugut AI, Ahsan H, Antman KH. Incidence of malignant mesothelioma after thoracic radiotherapy. Cancer 1997; 80: 948–950
Ng CS, Munden RF, Libshitz HI: Malignant pleural meso-thelioma: The spectrum of manifestations on CT in 70 cases. Clin Radiol 1999; 54: 415–421
Okamura H, Kamei T, Mitsuno A et al. Localized malignant mesothelioma of the pleura. Pathol Int 2001; 51: 654–660
Ong ST, Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma. A review. J Clin Oncol 1996; 14: 1007–1017
Patz EF Jr, Lowe VJ, Hoffmann JM et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188: 487–490
Patz EF Jr, Shaffer K, Piwnica-Worms DR et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting respectability. AJR Am J Roentgenol 1992; 159: 961–966
Peto J, Recarli A, La Vecchia C et al. The European mesothelioma epidemic. Br J Cancer 1999; 79: 666–672
Pilatte Y, Vivo C, Renier A et al. Absence of SV40 large T-antigen expression in human mesothelioma cell lines. Am J Respir Cell Mol Biol 2000; 23: 788–793
Pisani RJ, Colby TV, Williams DE. Malignant mesothelioma of the pleura. Mayo Clin Proc 1988; 63: 1234–1244
Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997; 145: 211–218
Rojas JL, Alfageme I, De la Cruz I et al. Radicular involvement and medullary invasion from a malignant mesothelioma. Respiration 2001; 68: 106–108
Rusch VW, Godwin JD, Shuman WP. The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1988; 96: 171–177
Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 1995; 108: 1122–1128
Sargent EL, Boswell WD, Ralls PW et al. Subpleural fat pads in patients exposed to asbestos: Distinction from noncalcified pleural plaques. Radiology 1984; 152: 273–277
Schneider DB, Clary-Macy C, Challa S et al. Positron emission tomography with F18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2000; 120: 128–133
Schwartz DA, Fourtes LJ, Galvin JR et al. Asbestos-induced pleural fibrosis and impaired lung function. Am Rev Respir Dis 1990; 141: 321–326
Senyigit A, Bayram H, Babayigit C et al. Malignant pleural mesothelioma caused by environmental exposure to asbes-tos in the southeast of turkey: CT findings in 117 patients. Clin Invest Resp 2000; 67: 615–622
Shuman LS, Libshitz HI. Solid pleural manifestations of lymphoma. AJR Am J Roentgenol 1984; 142: 269–273
Sterman DH, Treat J, Litzky LA et al. Adenovirus-mediated herpes simplex virus with thymidine kinase/gancicolvir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 1998; 9: 1083–1092
Sugarbaker DJ, Flores RM, Jaklitsch MT et al.: Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999; 117: 54–63
Takita H, Dougherthy TJ. Intracavitary photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol 1995;11: 368–371
Valk PE, Pounds TR, Hopkins DM et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1995; 60: 1573–1582
Walker AM, Loughlin JE, Friedlander ER et al. Projections of asbestos-related disease 1980–2009. J Occup Med 1983; 25: 409–425
Wechsler RJ, Rao VM, Steiner RM. The radiology of thoracic malignant mesothelioma. Crit Rev Diagn Imaging 1984; 20:283–310
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Eibel, R., Tuengerthal, S., Schönberg, S. (2005). Neue Möglichkeiten der modernen Bildgebung für Diagnose und Stadieneinteilung. In: Pleuramesotheliom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27329-8_4
Download citation
DOI: https://doi.org/10.1007/3-540-27329-8_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23014-4
Online ISBN: 978-3-540-27329-5
eBook Packages: Medicine (German Language)